SlideShare a Scribd company logo
CSI - CRANIO-SPINAL IRRADIATION
3/15/2023 1
DR KANHU CHARAN PATRO
MD,DNB(Radiation Oncology),MBA,FICRO,FAROI(USA),PDCR,CEPC
HOD,RADIATION ONCOLOGY
Mahatma Gandhi Cancer Hospital And Research Institute, Visakhapatnam
drkcpatro@gmail.com /M- +91-9160470564
What is this?
• Total neuroaxis radiation
• Brain and spine
• CSF spaces
– Brain
– Spine
– Cranial nerves
– Spinal nerve roots
Why is this?
• CSF spread
– Medulloblastoma
– Germ cell tumors
– Anaplastic ependymoma
– PNETs
– Pineoblastomas
– CNS Neuroaxis Mets
Who has given the concept?
The first article?
• Medulloblastomas are the most common
malignant brain tumour of childhood.
• They most commonly present as midline masses in
the roof of the 4th ventricle with associated mass
effect and hydrocephalus.
• Treatment typically consists of surgical resection,
radiation therapy, and chemotherapy, with the
prognosis strongly influenced by surgical resection,
the presence of CSF metastases at the time of
diagnosis
• 2021 update of the WHO classification of CNS
tumours, which recognizes four molecular subgroups
• The radiographic features are strongly influenced by
the histological type and molecular subtype of the
tumour
Introduction
IMAGING IN
MEDULLOBLASTOMA
CT PICTURE
CT PICTURE
CT CONTRAST
T1 CONTRAST
T1 CONTRAST
T2
T2 FLAIR
DWI
DWI-ADC
PERFUSION
Morphological risk stratification
Risk stratification
Molecular risk stratification
Radiogenomics
Simple algorithm
Surgical principle
1. However, routine pre-operative ventriculo-peritoneal (VP) shunt should
generally be avoided[ as definitive surgical resection readily relieves the
obstructionby opening the cerebrospinal fluid (CSF) pathways.
2. Besides the possible morbidity associated with a VP shunt, it can lead to
‘reverse herniation’ of the superior vermis into the quadrigeminal cistern and
occasionally seeding of the tumor into the peritoneal cavity.
3. Occasionally, CSF diversion may be deemed necessary for symptomatic relief
if there is anticipated delay in definitive surgery.
4. Such diversion is best achieved using either an external ventricular drainage
(EVD) or an endoscopic third ventriculostomy ((ETV)
5. If CSF diversion is not being considered, medical decompressive therapy is
recommended in the pre-operative period.
6. The steroid of choice is dexamethasone administered in a loading dose of
0.5-1 mg/kg intravenously (with the maximum dose being 10 mg
7. Complete surgical removal should be tried.
Chemotherapy
Adjuvant Chemotherapy
Concurrent Chemotherapy
1. Concurrent weekly vincristine (1.5mg/m2) given as an
intravenous bolus throughout the course of RT is
recommended (as in the original Packer’s regimen) for
children with standard risk disease being treated with
reduced dose CSI.
2. For children with high risk medulloblastoma, the use of
daily concurrent carboplatin (35mg/m2) as a short
intravenous infusion throughout the course of RT has
demonstrated very promising outcomes with
manageable acute toxicity and it is left to the discretion
of the treating physician whether to employ concurrent
carboplatin in routine clinical practice
Radiation principle
1. Whole neuroaxis radiation followed by tumor bed boost
is the standard
2. Children below 3 years need chemo till 3 years and
need radiation after that
TRAGET DELINEATION
• Craniospinal
– Whole brain
• Cribriform plate
• Skull base
• Cranial nerves
• Foramina
– Spine
• Entire subarachnoid space to
encompass the extensions along the
nerve roots laterally
Since the entire CSF space is at risk
of disease dissemination, the entire
arachnoid space is defined as the
CTV
TRAGET DELINEATION
GUIDELINES-1
GUIDELINES- 2
GUIDELINES- 3
IMAGING PROTOCOL
• From vertex to mid thigh
• CT
• MR spine T2
• MR brain FIESTA/ T1
FSPGR/T2
• 1-3mm slice
SIOPE
COG PROTOCOL
The missing target
cribriform plate
Ensure that the cribriform plate (suggested
CT window/ level: 3000/400),
The missing target
THE cribriform plate
1. Cribriform plate is a thin horizontal
plate of ethmoid bone which is
bounded laterally by vertical
lateral lamella
2. Includes brain with entire frontal lobe
and cribriform plate.
The missing target
Lower Part Of Temporal Lobe
The missing target
foramina
The missing target
foramina
1. Cranial nerve roots with their individual ‘dural
sheaths and spinal nerve roots as they emerge
from neural foramen within the high-dose
radiotherapy region
2. The observation on MRI of CSF flow beyond the
inner table of the skull into cranial nerve
foramina and canals raises
3. The issue of accurate delineation of all CSF
spaces as CTV for CSI
4. The SIOPE approach recommends a 5-mm
margin inferior to the cribriform plate and 10-
mm below the rest of the skull base whereas
5. Children’s Oncology Group (COG) advises a
uniform margin of 5 mm below the skull base
The dural cuff of cranial nerves
The dural cuff of cranial nerves
The FIESTA sequence
CTV CRANIAL NERVES
CTV OPTIC NERVES
CTV TRIGEMINAL -CAVE
CTV IAC
Cochlea sparing
• Attempts to spare the cochlea by
excluding CSF within the internal
auditory canal should be
avoided.
CTV jugular foramen
CTV hypoglossal
CTV FORAMINA
CTV FORAMINA
Pituitary sparing
The whole pituitary fossa
should be included in
CSI but not in boost
planning
CTV spinal
• CTV spinal including the entire
arachnoid space with nerve roots
CTV sacral canal
IS SPADE FIELD NECESSARY?
END OF SPINAL CORD
CONUS
END OF THECAL SAC
Determination of end of
thecal sac
Determination of thecal sac
Vertebra
The parts of the vertebrae bearing growing plates (the body of the vertebra, the
posterior element and facet joints; but not the lateral elements and transverse
processes) should be enclosed to a uniform dose
Vertebral foramen
Vertebral foramen
Vertebral Foramen
Spinal field 2 D plan
The PTV margin
The PTV margin should be
based on departmental data.
Most institutions add a 3–5
mm margin to CTV cranial
5–8 mm margin to CTV
spinal.
MLC CRANIAL FIELD
Timing of radiation
• Adjuvant RT should ideally begin as early as is
feasible (allowing 2-3 weeks for post-operative
recovery and neuraxial staging), preferably within
4-weeks, but within 6-weeks of surgery.
• The overall treatment time of fractionated course of
RT should preferably not exceed 50 days, but not 8
weeks
• Treatment interruptions during RT are undesirable
and should be avoided as far as practical
Pre RT investigations
• Full MRI brain and spine till mid thigh
• CSF study for malignant cells
Imaging in post op
1. It is recommended that post-operative MRI of the
brain be acquired immediately (within 24-48 hours
of surgical resection) to accurately identify the
extent of resection and quantify the status of the
residual disease.
2. However, whenever immediate post-operative
neuro-imaging has not been obtained, it is
recommended to wait for 2-3 weeks (but no later
than 4-weeks) to allow resolution of post-operative
changes (blood products and surgical debris) for
better delineation and characterization of the tumor
bed.
3. If screening spinal imaging had not been done
pre-operatively, the same should be acquired
post-operatively for an accurate spinal staging.
4. Once again, it is recommended to wait for 2-3
weeks after surgery for acquiring the spinal MRI to
reduce the chance of erroneous interpretation
consequent to post-operative enhancement of
spinal leptomeninges
CSF study?
• It is recommended to test the CSF for malignant cell
cytology via. lumbar puncture as a part of the
post-operative staging work-up
• This should be performed at least 2-3 weeks after
surgery to avoid false positivity.
• CSF obtained via a ventricular tap at the time of
surgery is not considered appropriate for neuraxial
staging
MRI AND CSF STUDY
which is first?
• Do CSF study after MRI
• Because LP site gives artifact Wrong interpretation of drop mets
• If CSF done first wait for 1/2 week
• Ask for sagittal MRI slice proper visualization
MRI drop
mets
Supine or prone?
• Supine – Subject(patient) comfort
• Prone – Physician comfort
2D/3D/ARC?
• Any
– 2D- Crude
– 3D- Better
– ARC- Wow
Why so special?
• Total length
• Field size less – 40cm x 40 cm
• Roughly 80-100 cm
• Junction
• Lateral cranial and anterior in
spinal
Where is the problem?
What is our aim?
• Homogenous dose to target
• Less dose to OAR
• Less integral dose
The prone position
CENTRAL ALIGNMENT ALONG SPINE
Is hair cut necessary?
Prone head rest- A- E
Kids
Those requiring anesthesia
CUT AROUND EAR
SEE THE GAP
BETWEEN MASK AND VERTEX
MASK AND SHOULDER
Alignment of the thoracic & lumbar spine parallel to
the couch
Thermocol wedge
THERMOCOL
HAIR BAND FOR FEET
The supine position
The portals
1. Whole Brain: Two parallel opposed lateral
field.
2. UPPER Spine: Direct Posterior field
3. LOWEER Spine: Direct Posterior field
How to fix the junction?
• Playing with
– Gantry
– Couch
– Collimation
• Junction shift or feathering
– Daily
– weekly
Sagittal junction
How to fix the junction?
Cranial and spinal
Sagittal junction
How to fix the junction?
Cranial and spinal
How to fix the junction?
Beam overlap
collimator correction
Beam overlap
collimator correction
How to fix the junction coronal?
How to fix the junction coronal?
How to fix the junction coronal?
How to fix the junction coronal?
How to fix the junction coronal?
How to fix the junction coronal?
How to fix the junction coronal?
Beam overlap
couch correction
Beam overlap
couch correction
The couch game
The couch game
Final
How to fix the junction?
Cranial and spinal
CAN I USE HALF BEAM BLOCK?
How to fix the junction?
Cranial and spinal
Half beam block
How to fix the junction?
Half beam block
Spinal and spinal field
Spinal and spinal field
Spinal and spinal field
how much gap?
Spinal and spinal field
how much gap?
Spinal and spinal field
how much gap?
Beam overlap spinal - spinal
Beam overlap spinal – spinal
Gantry correction
Beam overlap spinal – spinal
Gantry correction
GANTRY ANGLE WITH COUCH
ROTATION
How many junction required?
• Each beam 40 cm
• Keep 3 cm for junction shift
• 37cm
• If length of treatment
– 40cm-combination of two half beams [rare]
– 74 cm – one junction
– More than 74 cm-2 junctions
• Combination of half beam and divergent
beam
• Or all divergent beam
Make junction marks
CJN1, CJN2,CJN3
SJN1, SJN2,SJN3
Feathering or junction shift?
Where to put cranio-spinal
junction
• Ensure that spinal field
should not exit through
oral cavity and thyroid if
possible
• At least clearance from
shoulder is required in
lateral cranial field
Where to keep spinal-spinal
junction
The BLUE LINE AND RED LINE
CONCEPT
First plan
1st junction shift
2nd junction shift
EVERYDAY SETUP CHECK LIST
1. POSITION
2. ALLIGNMENT LASER
3. GAP BETWEEN MASK AND HEAD
4. ANY SHOULDER GAP
5. LEG AND FEET POSITION
6. LOWER BORADER OF CRANIAL AND UPPER BORDER OF SPINAL
DATE RL CRANIAL LL CRANIAL
GANTRY COLL. COUCH SSD GANTRY COLL. COUCH SSD
90 10 10 93 270 350 350 93
DAY1
DAY 2
DAY 3
DAY 4
DAY 5
DAY 6
DAY 7
EVERYDAY SETUP CHECK LIST
1. POSITION
2. ALLIGNMENT LASER
3. GAP BETWEEN MASK AND HEAD
4. ANY SHOULDER GAP
5. LEG AND FEET POSITION
6. LOWER BORADER OF LOWER SPINAL FIELD AND UPPER BORDER OF LOWER SPINAL FIELD
DATE UPPER SPINE FIELD LOWER SPINE FIELD
GANTRY COLL. COUCH SSD GANTRY COLL. COUCH SSD
0 0 0 95 345 0 90 94
DAY1
DAY 2
DAY 3
DAY 4
DAY 5
DAY 6
DAY 7
The extended SSD
1. Advantage
• Single spinal field and circumventing the
issue of junction between two spinal fields
2. Disadvantage
• Higher percentage depth dose and greater
penumbra results in higher mean doses to
all anterior normal structures,(mandible,
esophagus, liver, lungs, heart, gonads and
thyroid gland)
Is extended SSD
recommended?
What dose?
• Total dose
– Whole neuroaxis dose + Boost dose
• Whole neuroaxis + Boost dose
– High risk
• CSI-35Gy/21#
• Boost -19.8Gy/11#
• Total -54.8Gy/33#
– Low risk
• CSI (23.4Gy/13#)
• Boost (30.6Gy/17#)
• Total - 54Gy/ 30#
What dose if leptomemningeal mets?
• Total dose
– Whole neuroaxis dose + Boost dose + brain and nodular
extra dose
• Whole neuroaxis + Boost dose
– High risk
• CSI-
– 39.6-40Gy/22-24#
• Boost
– -14.4Gy /8 #
• Focal nodular metastatic deposits brain
and spine
– 5.4-9Gy /3-5 #
Medications?
• Antiemetics
– Ondansetron
• Steroids -CAUTION
• Antiepileptics as per need
Investigations?
• Weekly CBP- Complete blood count
• [Hb/WBC/TPL]
If low blood count?
• Keep the boost plan ready and start boost
plan stop CSI plan, if neutropenia and
thrombocytopenia
How to handle myelosuppression?
• It is preferable to avoid using prophylactic growth
factors during CSI, unless deemed necessary.
• However, growth factors may need to be
administered to maintain an absolute neutrophil
count >1 × 109/L to prevent unnecessary treatment
interruptions.
• Similarly, platelet transfusions are not
recommended routinely for mild thrombocytopenia,
but should be reserved for grade 3 or worse
thrombocytopenia to maintain a platelet count >50 ×
109/L during CSI
Using of steroid during treatment?
• The routine use of steroids (dexamethasone or
prednisone) is strongly discouraged unless
necessary (e.g. features of raised intra-cranial
pressure or therapy-induced intractable delayed
nausea/vomiting)
Concurrent chemo during radiotherapy?
• Concurrent weekly vincristine (1.5mg/m2) given
as an intravenous bolus throughout the course of RT
is recommended (as in the original Packer’s
regimen) for children with standard risk disease
being treated with reduced dose CSI.
• For children with high risk medulloblastoma, the use
of daily concurrent carboplatin (35mg/m2) as a
short intravenous infusion throughout the course of
RT has demonstrated very promising outcomes with
manageable acute toxicity and it is left to the
discretion of the treating physician whether to
employ concurrent carboplatin in routine clinical
practice
Boost
• Local
• Whole posterior fossa
Posterior fossa Boost
Tumor bed boost
2D to Tumor bed boost
OARs?
The dose to anterior vertebra
The VMAT plan
The VMAT plan
The VMAT plan comparison
The TOMO plan
The TOMO plan
SUMMARY
1. CSI is needed in medulloblastoma
2. You can plan with 2D/3D
3. Daily set up needed
4. Weekly junction shift is fine
5. If possible, plan with VMAT/TOMO
6. In TOMO no junction required if treatment
length 130cm
7. If not sure about molecular profile plan with
standard dose
8. Still posterior fossa boost is standard
9. In CBCT verification with 2 /3points required
10. Problem comes with longitudinal as you may
get longitudinal{Y} shifts every iso
11. Move only one site longitudinal {Y}
12. No need to move all sites longitudinal
movements {Y}
13. Only change lateral {x} and vertical{z}
14. Plan concurrent chemo
15. Send for adjutant chemo
Follow UP?
• Follow-up assessment should include a detailed physical
examination including evaluation of the neurological status and a
pro-active surveillance of the treatment-related late effects
– 3-monthly for the first 2-years,
– 6 monthly till 5-years,
– Annually thereafter
• Contrast-enhanced MRI of the brain and spine is recommended at
6-12 weeks after completion of all therapy to serve as a baseline for
future comparison
• Routine imaging surveillance is not recommended, but should be
ordered only if neurologic worsening occurs, recurrence/
progression of disease is suspected,

More Related Content

What's hot

Role of Conformal Radiotherapy in HNC
Role of Conformal Radiotherapy in HNCRole of Conformal Radiotherapy in HNC
Role of Conformal Radiotherapy in HNC
Sasikumar Sambasivam
 
Stereotactic body radiation therapy
Stereotactic body radiation therapyStereotactic body radiation therapy
Stereotactic body radiation therapy
umesh V
 
Head and neck reirradiation
Head and neck reirradiationHead and neck reirradiation
Head and neck reirradiation
Kanhu Charan
 
APBI-Dr Kiran
APBI-Dr Kiran APBI-Dr Kiran
APBI-Dr Kiran
Kiran Ramakrishna
 
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
Kiran Ramakrishna
 
Techniques for Inguinal/Groin Irradiation
Techniques for Inguinal/Groin IrradiationTechniques for Inguinal/Groin Irradiation
Techniques for Inguinal/Groin Irradiation
Ajeet Gandhi
 
Radiotherapy planning for rectal cancer ,2D updates!
Radiotherapy planning for rectal cancer ,2D   updates!Radiotherapy planning for rectal cancer ,2D   updates!
Radiotherapy planning for rectal cancer ,2D updates!
Gebrekirstos Hagos Gebrekirstos, MD
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
DrAyush Garg
 
Radiotherapy For Non Small Cell Lung Cancer
Radiotherapy For Non Small Cell Lung CancerRadiotherapy For Non Small Cell Lung Cancer
Radiotherapy For Non Small Cell Lung Cancerfondas vakalis
 
OVERVIEW OF SRS/SRT IN BRAIN TUMORS
OVERVIEW OF SRS/SRT IN BRAIN TUMORSOVERVIEW OF SRS/SRT IN BRAIN TUMORS
OVERVIEW OF SRS/SRT IN BRAIN TUMORS
Kanhu Charan
 
Hemi body irradiation
Hemi body irradiationHemi body irradiation
Hemi body irradiation
Nilesh Kucha
 
Intra Operative Radiotherapy
Intra Operative RadiotherapyIntra Operative Radiotherapy
Intra Operative Radiotherapy
Sasikumar Sambasivam
 
SBRT Contouring Guidelines
SBRT  Contouring  GuidelinesSBRT  Contouring  Guidelines
SBRT Contouring Guidelines
Dr Rushi Panchal
 
SBRT in lung cancer
SBRT in lung cancerSBRT in lung cancer
SBRT in lung cancer
Bharti Devnani
 
Prophylactic cranial irradiation
Prophylactic cranial irradiationProphylactic cranial irradiation
Prophylactic cranial irradiation
spa718
 
RE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCERRE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCER
MUNEER khalam
 
PENTEC GUIDELINES FOR PAEDIATRIC RADIOTHERAPY
PENTEC GUIDELINES FOR PAEDIATRIC RADIOTHERAPYPENTEC GUIDELINES FOR PAEDIATRIC RADIOTHERAPY
PENTEC GUIDELINES FOR PAEDIATRIC RADIOTHERAPY
Kanhu Charan
 
Quantec dr. upasna saxena (2)
Quantec   dr. upasna saxena (2)Quantec   dr. upasna saxena (2)
Quantec dr. upasna saxena (2)
Upasna Saxena
 

What's hot (20)

Role of Conformal Radiotherapy in HNC
Role of Conformal Radiotherapy in HNCRole of Conformal Radiotherapy in HNC
Role of Conformal Radiotherapy in HNC
 
Stereotactic body radiation therapy
Stereotactic body radiation therapyStereotactic body radiation therapy
Stereotactic body radiation therapy
 
Head and neck reirradiation
Head and neck reirradiationHead and neck reirradiation
Head and neck reirradiation
 
APBI-Dr Kiran
APBI-Dr Kiran APBI-Dr Kiran
APBI-Dr Kiran
 
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
 
Techniques for Inguinal/Groin Irradiation
Techniques for Inguinal/Groin IrradiationTechniques for Inguinal/Groin Irradiation
Techniques for Inguinal/Groin Irradiation
 
Radiotherapy planning for rectal cancer ,2D updates!
Radiotherapy planning for rectal cancer ,2D   updates!Radiotherapy planning for rectal cancer ,2D   updates!
Radiotherapy planning for rectal cancer ,2D updates!
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
 
Radiotherapy For Non Small Cell Lung Cancer
Radiotherapy For Non Small Cell Lung CancerRadiotherapy For Non Small Cell Lung Cancer
Radiotherapy For Non Small Cell Lung Cancer
 
OVERVIEW OF SRS/SRT IN BRAIN TUMORS
OVERVIEW OF SRS/SRT IN BRAIN TUMORSOVERVIEW OF SRS/SRT IN BRAIN TUMORS
OVERVIEW OF SRS/SRT IN BRAIN TUMORS
 
Hemi body irradiation
Hemi body irradiationHemi body irradiation
Hemi body irradiation
 
Intra Operative Radiotherapy
Intra Operative RadiotherapyIntra Operative Radiotherapy
Intra Operative Radiotherapy
 
SBRT Contouring Guidelines
SBRT  Contouring  GuidelinesSBRT  Contouring  Guidelines
SBRT Contouring Guidelines
 
SBRT in lung cancer
SBRT in lung cancerSBRT in lung cancer
SBRT in lung cancer
 
Prophylactic cranial irradiation
Prophylactic cranial irradiationProphylactic cranial irradiation
Prophylactic cranial irradiation
 
Radiation for Lung Cancer
Radiation for Lung CancerRadiation for Lung Cancer
Radiation for Lung Cancer
 
craniospinal irradiation
craniospinal irradiationcraniospinal irradiation
craniospinal irradiation
 
RE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCERRE-IRRADIATION IN HEAD AND NECK CANCER
RE-IRRADIATION IN HEAD AND NECK CANCER
 
PENTEC GUIDELINES FOR PAEDIATRIC RADIOTHERAPY
PENTEC GUIDELINES FOR PAEDIATRIC RADIOTHERAPYPENTEC GUIDELINES FOR PAEDIATRIC RADIOTHERAPY
PENTEC GUIDELINES FOR PAEDIATRIC RADIOTHERAPY
 
Quantec dr. upasna saxena (2)
Quantec   dr. upasna saxena (2)Quantec   dr. upasna saxena (2)
Quantec dr. upasna saxena (2)
 

Similar to PRACTICALITY OF CRANIOSPINALIRRADIATION

Craniospinal irradiation
Craniospinal irradiationCraniospinal irradiation
Craniospinal irradiation
Swarnita Sahu
 
Medulloblastoma
MedulloblastomaMedulloblastoma
Medulloblastoma
SavioJames4
 
Puneet medulloblastoma ppt
Puneet medulloblastoma pptPuneet medulloblastoma ppt
Puneet medulloblastoma ppt
drpuneetkumarbagri
 
Radiotherapy in carcinoma breast
Radiotherapy in carcinoma breastRadiotherapy in carcinoma breast
Radiotherapy in carcinoma breast
Sailendra Parida
 
craniospinal irradiation
craniospinal irradiation craniospinal irradiation
craniospinal irradiation
Mohammad Ashour
 
CT Myelography
CT MyelographyCT Myelography
CT Myelography
Subodhraj Dhungana
 
MRI Brain
MRI BrainMRI Brain
MRI Brain
Jayanti Gyawali
 
CSI.pptx
CSI.pptxCSI.pptx
Crcaniopharyngioma final ppt (2)
Crcaniopharyngioma final ppt (2)Crcaniopharyngioma final ppt (2)
Crcaniopharyngioma final ppt (2)
Usman Haqqani
 
Medulloblastoma n csi kiran
Medulloblastoma n csi kiranMedulloblastoma n csi kiran
Medulloblastoma n csi kiran
Kiran Ramakrishna
 
Radiotherapy Breast Cancer
Radiotherapy Breast CancerRadiotherapy Breast Cancer
Radiotherapy Breast Cancer
Mohamed Ali Morsy
 
Stereotactic radiosurgery and radiotherapy
Stereotactic radiosurgery and radiotherapyStereotactic radiosurgery and radiotherapy
Stereotactic radiosurgery and radiotherapy
umesh V
 
Supratentorial masses excision -anaesthetic implication
Supratentorial masses excision -anaesthetic implication Supratentorial masses excision -anaesthetic implication
Supratentorial masses excision -anaesthetic implication
ZIKRULLAH MALLICK
 
Medulloblastoma
Medulloblastoma Medulloblastoma
Medulloblastoma
Mohammad Ashour
 
ARROCase_SpineSBRT (1).pdf
ARROCase_SpineSBRT (1).pdfARROCase_SpineSBRT (1).pdf
ARROCase_SpineSBRT (1).pdf
Harpreetsaini64
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
Kanhu Charan
 
Brain tumors
Brain tumorsBrain tumors
Brain tumors
Swarnita Sahu
 
CRANIOSPINAL IRRADIATION-PART 1
CRANIOSPINAL IRRADIATION-PART 1CRANIOSPINAL IRRADIATION-PART 1
CRANIOSPINAL IRRADIATION-PART 1
Rejil Rajan
 
skeletal metastasis .pptx
skeletal metastasis .pptxskeletal metastasis .pptx
skeletal metastasis .pptx
mohammadabdulnaveed
 
Parotidectomy
ParotidectomyParotidectomy
Parotidectomy
shalinisinghchauhan
 

Similar to PRACTICALITY OF CRANIOSPINALIRRADIATION (20)

Craniospinal irradiation
Craniospinal irradiationCraniospinal irradiation
Craniospinal irradiation
 
Medulloblastoma
MedulloblastomaMedulloblastoma
Medulloblastoma
 
Puneet medulloblastoma ppt
Puneet medulloblastoma pptPuneet medulloblastoma ppt
Puneet medulloblastoma ppt
 
Radiotherapy in carcinoma breast
Radiotherapy in carcinoma breastRadiotherapy in carcinoma breast
Radiotherapy in carcinoma breast
 
craniospinal irradiation
craniospinal irradiation craniospinal irradiation
craniospinal irradiation
 
CT Myelography
CT MyelographyCT Myelography
CT Myelography
 
MRI Brain
MRI BrainMRI Brain
MRI Brain
 
CSI.pptx
CSI.pptxCSI.pptx
CSI.pptx
 
Crcaniopharyngioma final ppt (2)
Crcaniopharyngioma final ppt (2)Crcaniopharyngioma final ppt (2)
Crcaniopharyngioma final ppt (2)
 
Medulloblastoma n csi kiran
Medulloblastoma n csi kiranMedulloblastoma n csi kiran
Medulloblastoma n csi kiran
 
Radiotherapy Breast Cancer
Radiotherapy Breast CancerRadiotherapy Breast Cancer
Radiotherapy Breast Cancer
 
Stereotactic radiosurgery and radiotherapy
Stereotactic radiosurgery and radiotherapyStereotactic radiosurgery and radiotherapy
Stereotactic radiosurgery and radiotherapy
 
Supratentorial masses excision -anaesthetic implication
Supratentorial masses excision -anaesthetic implication Supratentorial masses excision -anaesthetic implication
Supratentorial masses excision -anaesthetic implication
 
Medulloblastoma
Medulloblastoma Medulloblastoma
Medulloblastoma
 
ARROCase_SpineSBRT (1).pdf
ARROCase_SpineSBRT (1).pdfARROCase_SpineSBRT (1).pdf
ARROCase_SpineSBRT (1).pdf
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Brain tumors
Brain tumorsBrain tumors
Brain tumors
 
CRANIOSPINAL IRRADIATION-PART 1
CRANIOSPINAL IRRADIATION-PART 1CRANIOSPINAL IRRADIATION-PART 1
CRANIOSPINAL IRRADIATION-PART 1
 
skeletal metastasis .pptx
skeletal metastasis .pptxskeletal metastasis .pptx
skeletal metastasis .pptx
 
Parotidectomy
ParotidectomyParotidectomy
Parotidectomy
 

More from Kanhu Charan

MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATROMOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
Kanhu Charan
 
MAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO
MAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATROMAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO
MAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO
Kanhu Charan
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
Kanhu Charan
 
TARGET DELINEATION OF THORACIC NODAL. STATION
TARGET DELINEATION OF THORACIC NODAL. STATIONTARGET DELINEATION OF THORACIC NODAL. STATION
TARGET DELINEATION OF THORACIC NODAL. STATION
Kanhu Charan
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
Kanhu Charan
 
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHUTARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
Kanhu Charan
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
Kanhu Charan
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
Kanhu Charan
 
Oncology cartoons by Dr Kanhu Charan Patro
Oncology cartoons by Dr Kanhu Charan PatroOncology cartoons by Dr Kanhu Charan Patro
Oncology cartoons by Dr Kanhu Charan Patro
Kanhu Charan
 
RADIATION THERAPY IN BILIARY TRACT CANCER
RADIATION THERAPY IN BILIARY TRACT CANCERRADIATION THERAPY IN BILIARY TRACT CANCER
RADIATION THERAPY IN BILIARY TRACT CANCER
Kanhu Charan
 
FEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUME
FEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUMEFEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUME
FEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUME
Kanhu Charan
 
Molecular Profile of Endometrial cancer.
Molecular Profile of Endometrial cancer.Molecular Profile of Endometrial cancer.
Molecular Profile of Endometrial cancer.
Kanhu Charan
 
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATROONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
Kanhu Charan
 
TYPES OF STATISTICAL DATA BY DR KANHU CHARAN PATRO
TYPES OF STATISTICAL DATA  BY DR KANHU CHARAN PATROTYPES OF STATISTICAL DATA  BY DR KANHU CHARAN PATRO
TYPES OF STATISTICAL DATA BY DR KANHU CHARAN PATRO
Kanhu Charan
 
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATROWHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
Kanhu Charan
 
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATROPORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
Kanhu Charan
 
DR KANHU CHARTAN PATRO/ FOR ENT SURGEONS
DR KANHU CHARTAN PATRO/ FOR ENT SURGEONSDR KANHU CHARTAN PATRO/ FOR ENT SURGEONS
DR KANHU CHARTAN PATRO/ FOR ENT SURGEONS
Kanhu Charan
 
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRODECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
Kanhu Charan
 
DEBATE IN CA BLADDER TMT VS CYSTECTOMY
DEBATE IN CA BLADDER TMT VS CYSTECTOMYDEBATE IN CA BLADDER TMT VS CYSTECTOMY
DEBATE IN CA BLADDER TMT VS CYSTECTOMY
Kanhu Charan
 
ROSE CASE CARDIAC ARRHYTHMIA SBRT
ROSE CASE CARDIAC  ARRHYTHMIA SBRTROSE CASE CARDIAC  ARRHYTHMIA SBRT
ROSE CASE CARDIAC ARRHYTHMIA SBRT
Kanhu Charan
 

More from Kanhu Charan (20)

MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATROMOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
 
MAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO
MAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATROMAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO
MAY 2024 ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
TARGET DELINEATION OF THORACIC NODAL. STATION
TARGET DELINEATION OF THORACIC NODAL. STATIONTARGET DELINEATION OF THORACIC NODAL. STATION
TARGET DELINEATION OF THORACIC NODAL. STATION
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHUTARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
TARGET DELINEATION IN ANAL CANAL CANCER BY DR KANHU
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
 
Oncology cartoons by Dr Kanhu Charan Patro
Oncology cartoons by Dr Kanhu Charan PatroOncology cartoons by Dr Kanhu Charan Patro
Oncology cartoons by Dr Kanhu Charan Patro
 
RADIATION THERAPY IN BILIARY TRACT CANCER
RADIATION THERAPY IN BILIARY TRACT CANCERRADIATION THERAPY IN BILIARY TRACT CANCER
RADIATION THERAPY IN BILIARY TRACT CANCER
 
FEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUME
FEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUMEFEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUME
FEBRUARY 2024 ONCOLOGY CARTOON /95TH VOLUME
 
Molecular Profile of Endometrial cancer.
Molecular Profile of Endometrial cancer.Molecular Profile of Endometrial cancer.
Molecular Profile of Endometrial cancer.
 
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATROONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
ONCOLOGY CARTOONS JANUARY 2024 BY DR KANHU CHARAN PATRO
 
TYPES OF STATISTICAL DATA BY DR KANHU CHARAN PATRO
TYPES OF STATISTICAL DATA  BY DR KANHU CHARAN PATROTYPES OF STATISTICAL DATA  BY DR KANHU CHARAN PATRO
TYPES OF STATISTICAL DATA BY DR KANHU CHARAN PATRO
 
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATROWHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
WHY STEREOTATXY IN CRANIAL AVM / DR KANHU CHARAN PATRO
 
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATROPORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
PORTAL VEIN TUMOR THROMBOSIS SBRT/DR KANHU CHRAN PATRO
 
DR KANHU CHARTAN PATRO/ FOR ENT SURGEONS
DR KANHU CHARTAN PATRO/ FOR ENT SURGEONSDR KANHU CHARTAN PATRO/ FOR ENT SURGEONS
DR KANHU CHARTAN PATRO/ FOR ENT SURGEONS
 
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRODECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
DECEMBER 2023 ONCOLOGY CARTOONS DRKANHU CHARAN PATRO
 
DEBATE IN CA BLADDER TMT VS CYSTECTOMY
DEBATE IN CA BLADDER TMT VS CYSTECTOMYDEBATE IN CA BLADDER TMT VS CYSTECTOMY
DEBATE IN CA BLADDER TMT VS CYSTECTOMY
 
ROSE CASE CARDIAC ARRHYTHMIA SBRT
ROSE CASE CARDIAC  ARRHYTHMIA SBRTROSE CASE CARDIAC  ARRHYTHMIA SBRT
ROSE CASE CARDIAC ARRHYTHMIA SBRT
 

Recently uploaded

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 

Recently uploaded (20)

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 

PRACTICALITY OF CRANIOSPINALIRRADIATION

  • 1. CSI - CRANIO-SPINAL IRRADIATION 3/15/2023 1 DR KANHU CHARAN PATRO MD,DNB(Radiation Oncology),MBA,FICRO,FAROI(USA),PDCR,CEPC HOD,RADIATION ONCOLOGY Mahatma Gandhi Cancer Hospital And Research Institute, Visakhapatnam drkcpatro@gmail.com /M- +91-9160470564
  • 2. What is this? • Total neuroaxis radiation • Brain and spine • CSF spaces – Brain – Spine – Cranial nerves – Spinal nerve roots
  • 3. Why is this? • CSF spread – Medulloblastoma – Germ cell tumors – Anaplastic ependymoma – PNETs – Pineoblastomas – CNS Neuroaxis Mets
  • 4. Who has given the concept?
  • 6. • Medulloblastomas are the most common malignant brain tumour of childhood. • They most commonly present as midline masses in the roof of the 4th ventricle with associated mass effect and hydrocephalus. • Treatment typically consists of surgical resection, radiation therapy, and chemotherapy, with the prognosis strongly influenced by surgical resection, the presence of CSF metastases at the time of diagnosis • 2021 update of the WHO classification of CNS tumours, which recognizes four molecular subgroups • The radiographic features are strongly influenced by the histological type and molecular subtype of the tumour Introduction
  • 13. T2
  • 15. DWI
  • 23. Surgical principle 1. However, routine pre-operative ventriculo-peritoneal (VP) shunt should generally be avoided[ as definitive surgical resection readily relieves the obstructionby opening the cerebrospinal fluid (CSF) pathways. 2. Besides the possible morbidity associated with a VP shunt, it can lead to ‘reverse herniation’ of the superior vermis into the quadrigeminal cistern and occasionally seeding of the tumor into the peritoneal cavity. 3. Occasionally, CSF diversion may be deemed necessary for symptomatic relief if there is anticipated delay in definitive surgery. 4. Such diversion is best achieved using either an external ventricular drainage (EVD) or an endoscopic third ventriculostomy ((ETV) 5. If CSF diversion is not being considered, medical decompressive therapy is recommended in the pre-operative period. 6. The steroid of choice is dexamethasone administered in a loading dose of 0.5-1 mg/kg intravenously (with the maximum dose being 10 mg 7. Complete surgical removal should be tried.
  • 26. Concurrent Chemotherapy 1. Concurrent weekly vincristine (1.5mg/m2) given as an intravenous bolus throughout the course of RT is recommended (as in the original Packer’s regimen) for children with standard risk disease being treated with reduced dose CSI. 2. For children with high risk medulloblastoma, the use of daily concurrent carboplatin (35mg/m2) as a short intravenous infusion throughout the course of RT has demonstrated very promising outcomes with manageable acute toxicity and it is left to the discretion of the treating physician whether to employ concurrent carboplatin in routine clinical practice
  • 27. Radiation principle 1. Whole neuroaxis radiation followed by tumor bed boost is the standard 2. Children below 3 years need chemo till 3 years and need radiation after that
  • 28. TRAGET DELINEATION • Craniospinal – Whole brain • Cribriform plate • Skull base • Cranial nerves • Foramina – Spine • Entire subarachnoid space to encompass the extensions along the nerve roots laterally Since the entire CSF space is at risk of disease dissemination, the entire arachnoid space is defined as the CTV
  • 33. IMAGING PROTOCOL • From vertex to mid thigh • CT • MR spine T2 • MR brain FIESTA/ T1 FSPGR/T2 • 1-3mm slice
  • 34. SIOPE
  • 36. The missing target cribriform plate Ensure that the cribriform plate (suggested CT window/ level: 3000/400),
  • 37. The missing target THE cribriform plate 1. Cribriform plate is a thin horizontal plate of ethmoid bone which is bounded laterally by vertical lateral lamella 2. Includes brain with entire frontal lobe and cribriform plate.
  • 38. The missing target Lower Part Of Temporal Lobe
  • 40. The missing target foramina 1. Cranial nerve roots with their individual ‘dural sheaths and spinal nerve roots as they emerge from neural foramen within the high-dose radiotherapy region 2. The observation on MRI of CSF flow beyond the inner table of the skull into cranial nerve foramina and canals raises 3. The issue of accurate delineation of all CSF spaces as CTV for CSI 4. The SIOPE approach recommends a 5-mm margin inferior to the cribriform plate and 10- mm below the rest of the skull base whereas 5. Children’s Oncology Group (COG) advises a uniform margin of 5 mm below the skull base
  • 41. The dural cuff of cranial nerves
  • 42. The dural cuff of cranial nerves
  • 48. Cochlea sparing • Attempts to spare the cochlea by excluding CSF within the internal auditory canal should be avoided.
  • 53. Pituitary sparing The whole pituitary fossa should be included in CSI but not in boost planning
  • 54. CTV spinal • CTV spinal including the entire arachnoid space with nerve roots
  • 56. IS SPADE FIELD NECESSARY?
  • 57. END OF SPINAL CORD CONUS
  • 59. Determination of end of thecal sac
  • 61. Vertebra The parts of the vertebrae bearing growing plates (the body of the vertebra, the posterior element and facet joints; but not the lateral elements and transverse processes) should be enclosed to a uniform dose
  • 65. Spinal field 2 D plan
  • 66. The PTV margin The PTV margin should be based on departmental data. Most institutions add a 3–5 mm margin to CTV cranial 5–8 mm margin to CTV spinal.
  • 68. Timing of radiation • Adjuvant RT should ideally begin as early as is feasible (allowing 2-3 weeks for post-operative recovery and neuraxial staging), preferably within 4-weeks, but within 6-weeks of surgery. • The overall treatment time of fractionated course of RT should preferably not exceed 50 days, but not 8 weeks • Treatment interruptions during RT are undesirable and should be avoided as far as practical
  • 69. Pre RT investigations • Full MRI brain and spine till mid thigh • CSF study for malignant cells
  • 70. Imaging in post op 1. It is recommended that post-operative MRI of the brain be acquired immediately (within 24-48 hours of surgical resection) to accurately identify the extent of resection and quantify the status of the residual disease. 2. However, whenever immediate post-operative neuro-imaging has not been obtained, it is recommended to wait for 2-3 weeks (but no later than 4-weeks) to allow resolution of post-operative changes (blood products and surgical debris) for better delineation and characterization of the tumor bed. 3. If screening spinal imaging had not been done pre-operatively, the same should be acquired post-operatively for an accurate spinal staging. 4. Once again, it is recommended to wait for 2-3 weeks after surgery for acquiring the spinal MRI to reduce the chance of erroneous interpretation consequent to post-operative enhancement of spinal leptomeninges
  • 71. CSF study? • It is recommended to test the CSF for malignant cell cytology via. lumbar puncture as a part of the post-operative staging work-up • This should be performed at least 2-3 weeks after surgery to avoid false positivity. • CSF obtained via a ventricular tap at the time of surgery is not considered appropriate for neuraxial staging
  • 72. MRI AND CSF STUDY which is first? • Do CSF study after MRI • Because LP site gives artifact Wrong interpretation of drop mets • If CSF done first wait for 1/2 week • Ask for sagittal MRI slice proper visualization
  • 74. Supine or prone? • Supine – Subject(patient) comfort • Prone – Physician comfort
  • 75. 2D/3D/ARC? • Any – 2D- Crude – 3D- Better – ARC- Wow
  • 76. Why so special? • Total length • Field size less – 40cm x 40 cm • Roughly 80-100 cm • Junction • Lateral cranial and anterior in spinal
  • 77. Where is the problem?
  • 78. What is our aim? • Homogenous dose to target • Less dose to OAR • Less integral dose
  • 81. Is hair cut necessary?
  • 85. SEE THE GAP BETWEEN MASK AND VERTEX MASK AND SHOULDER
  • 86. Alignment of the thoracic & lumbar spine parallel to the couch Thermocol wedge
  • 90. The portals 1. Whole Brain: Two parallel opposed lateral field. 2. UPPER Spine: Direct Posterior field 3. LOWEER Spine: Direct Posterior field
  • 91. How to fix the junction? • Playing with – Gantry – Couch – Collimation • Junction shift or feathering – Daily – weekly
  • 92. Sagittal junction How to fix the junction? Cranial and spinal
  • 93. Sagittal junction How to fix the junction? Cranial and spinal
  • 94. How to fix the junction?
  • 97. How to fix the junction coronal?
  • 98. How to fix the junction coronal?
  • 99. How to fix the junction coronal?
  • 100. How to fix the junction coronal?
  • 101. How to fix the junction coronal?
  • 102. How to fix the junction coronal?
  • 103. How to fix the junction coronal?
  • 108. Final
  • 109. How to fix the junction? Cranial and spinal CAN I USE HALF BEAM BLOCK?
  • 110. How to fix the junction? Cranial and spinal Half beam block
  • 111. How to fix the junction? Half beam block
  • 114. Spinal and spinal field how much gap?
  • 115. Spinal and spinal field how much gap?
  • 116. Spinal and spinal field how much gap?
  • 117. Beam overlap spinal - spinal
  • 118. Beam overlap spinal – spinal Gantry correction
  • 119. Beam overlap spinal – spinal Gantry correction
  • 120. GANTRY ANGLE WITH COUCH ROTATION
  • 121. How many junction required? • Each beam 40 cm • Keep 3 cm for junction shift • 37cm • If length of treatment – 40cm-combination of two half beams [rare] – 74 cm – one junction – More than 74 cm-2 junctions • Combination of half beam and divergent beam • Or all divergent beam
  • 122. Make junction marks CJN1, CJN2,CJN3 SJN1, SJN2,SJN3
  • 124. Where to put cranio-spinal junction • Ensure that spinal field should not exit through oral cavity and thyroid if possible • At least clearance from shoulder is required in lateral cranial field
  • 125. Where to keep spinal-spinal junction
  • 126. The BLUE LINE AND RED LINE CONCEPT
  • 130. EVERYDAY SETUP CHECK LIST 1. POSITION 2. ALLIGNMENT LASER 3. GAP BETWEEN MASK AND HEAD 4. ANY SHOULDER GAP 5. LEG AND FEET POSITION 6. LOWER BORADER OF CRANIAL AND UPPER BORDER OF SPINAL DATE RL CRANIAL LL CRANIAL GANTRY COLL. COUCH SSD GANTRY COLL. COUCH SSD 90 10 10 93 270 350 350 93 DAY1 DAY 2 DAY 3 DAY 4 DAY 5 DAY 6 DAY 7
  • 131. EVERYDAY SETUP CHECK LIST 1. POSITION 2. ALLIGNMENT LASER 3. GAP BETWEEN MASK AND HEAD 4. ANY SHOULDER GAP 5. LEG AND FEET POSITION 6. LOWER BORADER OF LOWER SPINAL FIELD AND UPPER BORDER OF LOWER SPINAL FIELD DATE UPPER SPINE FIELD LOWER SPINE FIELD GANTRY COLL. COUCH SSD GANTRY COLL. COUCH SSD 0 0 0 95 345 0 90 94 DAY1 DAY 2 DAY 3 DAY 4 DAY 5 DAY 6 DAY 7
  • 132. The extended SSD 1. Advantage • Single spinal field and circumventing the issue of junction between two spinal fields 2. Disadvantage • Higher percentage depth dose and greater penumbra results in higher mean doses to all anterior normal structures,(mandible, esophagus, liver, lungs, heart, gonads and thyroid gland)
  • 134. What dose? • Total dose – Whole neuroaxis dose + Boost dose • Whole neuroaxis + Boost dose – High risk • CSI-35Gy/21# • Boost -19.8Gy/11# • Total -54.8Gy/33# – Low risk • CSI (23.4Gy/13#) • Boost (30.6Gy/17#) • Total - 54Gy/ 30#
  • 135. What dose if leptomemningeal mets? • Total dose – Whole neuroaxis dose + Boost dose + brain and nodular extra dose • Whole neuroaxis + Boost dose – High risk • CSI- – 39.6-40Gy/22-24# • Boost – -14.4Gy /8 # • Focal nodular metastatic deposits brain and spine – 5.4-9Gy /3-5 #
  • 136. Medications? • Antiemetics – Ondansetron • Steroids -CAUTION • Antiepileptics as per need
  • 137. Investigations? • Weekly CBP- Complete blood count • [Hb/WBC/TPL]
  • 138. If low blood count? • Keep the boost plan ready and start boost plan stop CSI plan, if neutropenia and thrombocytopenia
  • 139. How to handle myelosuppression? • It is preferable to avoid using prophylactic growth factors during CSI, unless deemed necessary. • However, growth factors may need to be administered to maintain an absolute neutrophil count >1 × 109/L to prevent unnecessary treatment interruptions. • Similarly, platelet transfusions are not recommended routinely for mild thrombocytopenia, but should be reserved for grade 3 or worse thrombocytopenia to maintain a platelet count >50 × 109/L during CSI
  • 140. Using of steroid during treatment? • The routine use of steroids (dexamethasone or prednisone) is strongly discouraged unless necessary (e.g. features of raised intra-cranial pressure or therapy-induced intractable delayed nausea/vomiting)
  • 141. Concurrent chemo during radiotherapy? • Concurrent weekly vincristine (1.5mg/m2) given as an intravenous bolus throughout the course of RT is recommended (as in the original Packer’s regimen) for children with standard risk disease being treated with reduced dose CSI. • For children with high risk medulloblastoma, the use of daily concurrent carboplatin (35mg/m2) as a short intravenous infusion throughout the course of RT has demonstrated very promising outcomes with manageable acute toxicity and it is left to the discretion of the treating physician whether to employ concurrent carboplatin in routine clinical practice
  • 142. Boost • Local • Whole posterior fossa
  • 145. 2D to Tumor bed boost
  • 146. OARs?
  • 147. The dose to anterior vertebra
  • 150. The VMAT plan comparison
  • 153. SUMMARY 1. CSI is needed in medulloblastoma 2. You can plan with 2D/3D 3. Daily set up needed 4. Weekly junction shift is fine 5. If possible, plan with VMAT/TOMO 6. In TOMO no junction required if treatment length 130cm 7. If not sure about molecular profile plan with standard dose 8. Still posterior fossa boost is standard 9. In CBCT verification with 2 /3points required 10. Problem comes with longitudinal as you may get longitudinal{Y} shifts every iso 11. Move only one site longitudinal {Y} 12. No need to move all sites longitudinal movements {Y} 13. Only change lateral {x} and vertical{z} 14. Plan concurrent chemo 15. Send for adjutant chemo
  • 154. Follow UP? • Follow-up assessment should include a detailed physical examination including evaluation of the neurological status and a pro-active surveillance of the treatment-related late effects – 3-monthly for the first 2-years, – 6 monthly till 5-years, – Annually thereafter • Contrast-enhanced MRI of the brain and spine is recommended at 6-12 weeks after completion of all therapy to serve as a baseline for future comparison • Routine imaging surveillance is not recommended, but should be ordered only if neurologic worsening occurs, recurrence/ progression of disease is suspected,